Innovate UK Logo

ExpertiseUpdated on 15 June 2026

Evidence-led healthtech, medicines workflow and pilot-readiness

Founder, CEO at NEUVIOR® - UK Pharma Infrastructure

London, United Kingdom

About

commercialisation.

I’m building PHARMORIS around a simple problem: healthcare organisations often have medicines signals, dashboards and committee discussions, but the difficult part is converting those signals into owned actions, credible evidence, accountable review, blocker resolution and value tracking.

Areas I’m actively working through include:

• medicines optimisation workflow
• ActionCase and evidence-pack design
• source provenance and auditability
• human review and AI-assist boundaries
• pilot-readiness evidence
• clinical-safety awareness
• DTAC/DCB/DSPT readiness thinking
• buyer-safe healthtech positioning
• evidence-to-policy and evidence-to-procurement routes
• investor-grade pilot evidence

I’m very open to comparing notes with people working on regulation, standards, clinical safety, NHS innovation, medicines, AI assurance, medtech commercialisation and public-interest innovation.

Organisation

NEUVIOR® - UK Pharma Infrastructure

Businesses

London, United Kingdom

Similar opportunities